메뉴 건너뛰기




Volumn 126, Issue 21, 2013, Pages 4175-4182

Role of signaling pathways and miRNAs in chronic lymphocytic leukemia

Author keywords

Chronic lymphocytic leukemia; MiRNA; Signal pathway

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYCLIN D2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOID ENHANCER FACTOR 1; MICRORNA; MICRORNA 103; MICRORNA 106B; MICRORNA 132; MICRORNA 151 3P; MICRORNA 155; MICRORNA 15A; MICRORNA 181; MICRORNA 186; MICRORNA 195; MICRORNA 203; MICRORNA 213; MICRORNA 221; MICRORNA 222; MICRORNA 29A; MICRORNA 34A; MICRORNA 34B; MICRORNA 34C; MICRORNA 640; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

EID: 84887094217     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20130414     Document Type: Review
Times cited : (14)

References (100)
  • 1
    • 0035803371 scopus 로고    scopus 로고
    • Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
    • Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639-1647
    • (2001) J Exp Med , vol.194 , pp. 1639-1647
    • Rosenwald, A.1    Alizadeh, A.A.2    Widhopf, G.3    Simon, R.4    Davis, R.E.5    Yu, X.6
  • 2
    • 33644897592 scopus 로고    scopus 로고
    • Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel
    • Reddy KS. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel. Br J Haematol 2006; 132: 705-722
    • (2006) Br J Haematol , vol.132 , pp. 705-722
    • Reddy, K.S.1
  • 3
    • 79953187897 scopus 로고    scopus 로고
    • Importance of genetics in chronic lymphocytic leukemia
    • Zenz T, Mertens D, Döhner H, Stilgenbauer S. Importance of genetics in chronic lymphocytic leukemia. Blood Rev 2011; 25: 131-137
    • (2011) Blood Rev , vol.25 , pp. 131-137
    • Zenz, T.1    Mertens, D.2    Döhner, H.3    Stilgenbauer, S.4
  • 4
    • 80052008536 scopus 로고    scopus 로고
    • Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: A multicenter study
    • Lai YY, Huang XJ. Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study. Chin Med J 2011; 124: 2417-2422
    • (2011) Chin Med J , vol.124 , pp. 2417-2422
    • Lai, Y.Y.1    Huang, X.J.2
  • 5
    • 79954999804 scopus 로고    scopus 로고
    • Understanding and managing ultra high-risk chronic lymphocytic leukemia
    • Stilgenbauer S, Zenz T. Understanding and managing ultra high-risk chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2010; 2010: 481-488
    • (2010) Hematology Am Soc Hematol Educ Program , pp. 481-488
    • Stilgenbauer, S.1    Zenz, T.2
  • 6
    • 75649140955 scopus 로고    scopus 로고
    • How I treat CLL up front
    • Gribben JG. How I treat CLL up front. Blood 2010; 115: 187-197
    • (2010) Blood , vol.115 , pp. 187-197
    • Gribben, J.G.1
  • 7
    • 84860001611 scopus 로고    scopus 로고
    • Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: Any role for Notch, Wnt and Hh signaling pathways?
    • Seke Etet PF, Vecchio L, Nwabo Kamdje AH. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways? Cell Signal 2012; 24: 1433-1443
    • (2012) Cell Signal , vol.24 , pp. 1433-1443
    • Seke, E.P.F.1    Vecchio, L.2    Nwabo, K.A.H.3
  • 8
    • 74749107606 scopus 로고    scopus 로고
    • Cyclic adenosine monophosphate signal pathway in targeted therapy of lymphoma
    • Dou AX, Wang X. Cyclic adenosine monophosphate signal pathway in targeted therapy of lymphoma. Chin Med J 2010; 123: 95-99
    • (2010) Chin Med J , vol.123 , pp. 95-99
    • Dou, A.X.1    Wang, X.2
  • 9
    • 33750370444 scopus 로고    scopus 로고
    • MicroRNA signatures in human cancers
    • Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866
    • (2006) Nat Rev Cancer , vol.6 , pp. 857-866
    • Calin, G.A.1    Croce, C.M.2
  • 11
    • 79960713883 scopus 로고    scopus 로고
    • Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia
    • Colombo M, Cutrona G, Reverberi D, Fabris S, Neri A, Fabbi M, et al. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia. Mol Med 2011; 17: 834-839
    • (2011) Mol Med , vol.17 , pp. 834-839
    • Colombo, M.1    Cutrona, G.2    Reverberi, D.3    Fabris, S.4    Neri, A.5    Fabbi, M.6
  • 12
    • 77953647130 scopus 로고    scopus 로고
    • Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo
    • Krysov S, Potter KN, Mockridge CI, Coelho V, Wheatley I, Packham G, et al. Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo. Blood 2010; 115: 4198-4205
    • (2010) Blood , vol.115 , pp. 4198-4205
    • Krysov, S.1    Potter, K.N.2    Mockridge, C.I.3    Coelho, V.4    Wheatley, I.5    Packham, G.6
  • 13
    • 50949128066 scopus 로고    scopus 로고
    • BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells
    • Guarini A, Chiaretti S, Tavolaro S, Maggio R, Peragine N, Citarella F, et al. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. Blood 2008; 112: 782-792
    • (2008) Blood , vol.112 , pp. 782-792
    • Guarini, A.1    Chiaretti, S.2    Tavolaro, S.3    Maggio, R.4    Peragine, N.5    Citarella, F.6
  • 15
    • 70349237504 scopus 로고    scopus 로고
    • B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: Specific targeting with a novel spleen tyrosine kinase inhibitor, R406
    • Quiroga MP, Balakrishnan K, Kurtova AV, Sivina M, Keating MJ, Wierda WG, et al. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood 2009; 114: 1029-1037
    • (2009) Blood , vol.114 , pp. 1029-1037
    • Quiroga, M.P.1    Balakrishnan, K.2    Kurtova, A.V.3    Sivina, M.4    Keating, M.J.5    Wierda, W.G.6
  • 16
    • 64049093376 scopus 로고    scopus 로고
    • High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
    • Burger JA, Quiroga MP, Hartmann E, Bürkle A, Wierda WG, Keating MJ, et al. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood 2009; 113: 3050-3058
    • (2009) Blood , vol.113 , pp. 3050-3058
    • Burger, J.A.1    Quiroga, M.P.2    Hartmann, E.3    Bürkle, A.4    Wierda, W.G.5    Keating, M.J.6
  • 17
    • 78751549662 scopus 로고    scopus 로고
    • The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia
    • Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011; 117: 563-574
    • (2011) Blood , vol.117 , pp. 563-574
    • Herishanu, Y.1    Pérez-Galán, P.2    Liu, D.3    Biancotto, A.4    Pittaluga, S.5    Vire, B.6
  • 18
    • 78651227932 scopus 로고    scopus 로고
    • Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells
    • Binder M, Léchenne B, Ummanni R, Scharf C, Balabanov S, Trusch M, et al. Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells. PLoS One 2010; 5: e15992
    • (2010) PLoS One , vol.5
    • Binder, M.1    Léchenne, B.2    Ummanni, R.3    Scharf, C.4    Balabanov, S.5    Trusch, M.6
  • 19
    • 55749091407 scopus 로고    scopus 로고
    • Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA
    • Chu CC, Catera R, Hatzi K, Yan XJ, Zhang L, Wang XB, et al. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood 2008; 112: 5122-5129
    • (2008) Blood , vol.112 , pp. 5122-5129
    • Chu, C.C.1    Catera, R.2    Hatzi, K.3    Yan, X.J.4    Zhang, L.5    Wang, X.B.6
  • 20
    • 78649792807 scopus 로고    scopus 로고
    • The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia
    • Packham G, Stevenson F. The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia. Semin Cancer Biol 2010; 20: 391-399
    • (2010) Semin Cancer Biol , vol.20 , pp. 391-399
    • Packham, G.1    Stevenson, F.2
  • 21
    • 64849113027 scopus 로고    scopus 로고
    • Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells
    • Gobessi S, Laurenti L, Longo PG, Carsetti L, Berno V, Sica S, et al. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Leukemia 2009; 23: 686-697
    • (2009) Leukemia , vol.23 , pp. 686-697
    • Gobessi, S.1    Laurenti, L.2    Longo, P.G.3    Carsetti, L.4    Berno, V.5    Sica, S.6
  • 22
    • 84863393559 scopus 로고    scopus 로고
    • Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells
    • Krysov S, Dias S, Paterson A, Mockridge CI, Potter KN, Smith KA, et al. Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. Blood 2012; 119: 170-179
    • (2012) Blood , vol.119 , pp. 170-179
    • Krysov, S.1    Dias, S.2    Paterson, A.3    Mockridge, C.I.4    Potter, K.N.5    Smith, K.A.6
  • 23
    • 67650458526 scopus 로고    scopus 로고
    • Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia
    • Buchner M, Fuchs S, Prinz G, Pfeifer D, Bartholomé K, Burger M, et al. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. Cancer Res 2009; 69: 5424-5432
    • (2009) Cancer Res , vol.69 , pp. 5424-5432
    • Buchner, M.1    Fuchs, S.2    Prinz, G.3    Pfeifer, D.4    Bartholomé, K.5    Burger, M.6
  • 24
    • 0033485625 scopus 로고    scopus 로고
    • Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells
    • Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999; 94: 3658-3667
    • (1999) Blood , vol.94 , pp. 3658-3667
    • Burger, J.A.1    Burger, M.2    Kipps, T.J.3
  • 25
    • 77952886100 scopus 로고    scopus 로고
    • Spleen tyrosine kinase inhibition prevents chemokine-and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
    • Buchner M, Baer C, Prinz G, Dierks C, Burger M, Zenz T, et al. Spleen tyrosine kinase inhibition prevents chemokine-and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. Blood 2010; 115: 4497-4506
    • (2010) Blood , vol.115 , pp. 4497-4506
    • Buchner, M.1    Baer, C.2    Prinz, G.3    Dierks, C.4    Burger, M.5    Zenz, T.6
  • 26
    • 23944488816 scopus 로고    scopus 로고
    • Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
    • Burger M, Hartmann T, Krome M, Rawluk J, Tamamura H, Fujii N, et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 2005; 106: 1824-1830
    • (2005) Blood , vol.106 , pp. 1824-1830
    • Burger, M.1    Hartmann, T.2    Krome, M.3    Rawluk, J.4    Tamamura, H.5    Fujii, N.6
  • 27
    • 84863011553 scopus 로고    scopus 로고
    • The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
    • Ponader S, Chen SS, Buggy JJ, Balakrishnan K, Gandhi V, Wierda WG, et al. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood 2012; 119: 1182-1189
    • (2012) Blood , vol.119 , pp. 1182-1189
    • Ponader, S.1    Chen, S.S.2    Buggy, J.J.3    Balakrishnan, K.4    Gandhi, V.5    Wierda, W.G.6
  • 28
    • 67049137382 scopus 로고    scopus 로고
    • Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: A novel therapeutic approach
    • Niedermeier M, Hennessy BT, Knight ZA, Henneberg M, Hu J, Kurtova AV, et al. Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach. Blood 2009; 113: 5549-5557
    • (2009) Blood , vol.113 , pp. 5549-5557
    • Niedermeier, M.1    Hennessy, B.T.2    Knight, Z.A.3    Henneberg, M.4    Hu, J.5    Kurtova, A.V.6
  • 29
    • 78751553221 scopus 로고    scopus 로고
    • CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
    • Lannutti BJ, Meadows SA, Herman SE, Kashishian A, Steiner B, Johnson AJ, et al. CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood 2011; 117: 591-594
    • (2011) Blood , vol.117 , pp. 591-594
    • Lannutti, B.J.1    Meadows, S.A.2    Herman, S.E.3    Kashishian, A.4    Steiner, B.5    Johnson, A.J.6
  • 30
    • 77957201023 scopus 로고    scopus 로고
    • Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
    • Herman SE, Gordon AL, Wagner AJ, Heerema NA, Zhao W, Flynn JM, et al. Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals. Blood 2010; 116: 2078-2088
    • (2010) Blood , vol.116 , pp. 2078-2088
    • Herman, S.E.1    Gordon, A.L.2    Wagner, A.J.3    Heerema, N.A.4    Zhao, W.5    Flynn, J.M.6
  • 31
    • 0037100392 scopus 로고    scopus 로고
    • The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3
    • Christian SL, Sims PV, Gold MR. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3. J Immunol 2002; 169: 758-769
    • (2002) J Immunol , vol.169 , pp. 758-769
    • Christian, S.L.1    Sims, P.V.2    Gold, M.R.3
  • 33
    • 80355126549 scopus 로고    scopus 로고
    • Toll-like receptor signaling pathway in chronic lymphocytic leukemia: Distinct gene expression profiles of potential pathogenetic significance in specific subsets of patients
    • Arvaniti E, Ntoufa S, Papakonstantinou N, Touloumenidou T, Laoutaris N, Anagnostopoulos A, et al. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenetic significance in specific subsets of patients. Haematologica 2011
    • (2011) Haematologica
    • Arvaniti, E.1    Ntoufa, S.2    Papakonstantinou, N.3    Touloumenidou, T.4    Laoutaris, N.5    Anagnostopoulos, A.6
  • 34
    • 74049096598 scopus 로고    scopus 로고
    • Toll-like receptors on B-CLL cells: Expression and functional consequences of their stimulation
    • Rozková D, Novotná L, Pytlík R, Hochová I, Kozák T, Bartůnková J, et al. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation. Int J Cancer 2010; 126: 1132-1143
    • (2010) Int J Cancer , vol.126 , pp. 1132-1143
    • Rozková, D.1    Novotná, L.2    Pytlík, R.3    Hochová, I.4    Kozák, T.5    Bartůnková, J.6
  • 35
    • 33845542139 scopus 로고    scopus 로고
    • Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia
    • Spaner DE, Masellis A. Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia. Leukemia 2007; 21: 53-60
    • (2007) Leukemia , vol.21 , pp. 53-60
    • Spaner, D.E.1    Masellis, A.2
  • 36
    • 77954662424 scopus 로고    scopus 로고
    • Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells
    • Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, et al. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood 2010; 115: 5041-5052
    • (2010) Blood , vol.115 , pp. 5041-5052
    • Liang, X.1    Moseman, E.A.2    Farrar, M.A.3    Bachanova, V.4    Weisdorf, D.J.5    Blazar, B.R.6
  • 37
    • 79960691639 scopus 로고    scopus 로고
    • Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models
    • Bertilaccio MT, Simonetti G, Dagklis A, Rocchi M, Rodriguez TV, Apollonio B, et al. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. Blood 2011; 118: 660-669
    • (2011) Blood , vol.118 , pp. 660-669
    • Bertilaccio, M.T.1    Simonetti, G.2    Dagklis, A.3    Rocchi, M.4    Rodriguez, T.V.5    Apollonio, B.6
  • 38
    • 73949119120 scopus 로고    scopus 로고
    • Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: The therapeutic potential of Akt inhibition
    • Zhuang J, Hawkins SF, Glenn MA, Lin K, Johnson GG, Carter A, et al. Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition. Haematologica 2010; 95: 110-118
    • (2010) Haematologica , vol.95 , pp. 110-118
    • Zhuang, J.1    Hawkins, S.F.2    Glenn, M.A.3    Lin, K.4    Johnson, G.G.5    Carter, A.6
  • 39
    • 77951031861 scopus 로고    scopus 로고
    • CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia
    • Liu FT, Giustiniani J, Farren T, Jia L, Bensussan A, Gribben JG, et al. CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia. Blood 2010; 115: 3079-3088
    • (2010) Blood , vol.115 , pp. 3079-3088
    • Liu, F.T.1    Giustiniani, J.2    Farren, T.3    Jia, L.4    Bensussan, A.5    Gribben, J.G.6
  • 42
    • 23044514711 scopus 로고    scopus 로고
    • Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha
    • Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC, et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 2005; 106: 1012-1020
    • (2005) Blood , vol.106 , pp. 1012-1020
    • Nishio, M.1    Endo, T.2    Tsukada, N.3    Ohata, J.4    Kitada, S.5    Reed, J.C.6
  • 45
    • 84862938297 scopus 로고    scopus 로고
    • Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies
    • Gaudio E, Spizzo R, Paduano F, Luo Z, Efanov A, Palamarchuk A, et al. Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies. Blood 2012; 119: 180-187
    • (2012) Blood , vol.119 , pp. 180-187
    • Gaudio, E.1    Spizzo, R.2    Paduano, F.3    Luo, Z.4    Efanov, A.5    Palamarchuk, A.6
  • 46
    • 34547114509 scopus 로고    scopus 로고
    • Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells
    • Ougolkov AV, Bone ND, Fernandez-Zapico ME, Kay NE, Billadeau DD. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood 2007; 110: 735-742
    • (2007) Blood , vol.110 , pp. 735-742
    • Ougolkov, A.V.1    Bone, N.D.2    Fernandez-Zapico, M.E.3    Kay, N.E.4    Billadeau, D.D.5
  • 47
    • 80054969575 scopus 로고    scopus 로고
    • Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma
    • Igawa T, Sato Y, Takata K, Fushimi S, Tamura M, Nakamura N, et al. Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma. Cancer Sci 2011; 102: 2103-2107
    • (2011) Cancer Sci , vol.102 , pp. 2103-2107
    • Igawa, T.1    Sato, Y.2    Takata, K.3    Fushimi, S.4    Tamura, M.5    Nakamura, N.6
  • 48
    • 47149090375 scopus 로고    scopus 로고
    • The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
    • Hewamana S, Alghazal S, Lin TT, Clement M, Jenkins C, Guzman ML, et al. The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. Blood 2008; 111: 4681-4689
    • (2008) Blood , vol.111 , pp. 4681-4689
    • Hewamana, S.1    Alghazal, S.2    Lin, T.T.3    Clement, M.4    Jenkins, C.5    Guzman, M.L.6
  • 50
    • 59649083306 scopus 로고    scopus 로고
    • Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
    • Rosati E, Sabatini R, Rampino G, Tabilio A, Di Ianni M, Fettucciari K, et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009; 113: 856-865
    • (2009) Blood , vol.113 , pp. 856-865
    • Rosati, E.1    Sabatini, R.2    Rampino, G.3    Tabilio, A.4    Di Ianni, M.5    Fettucciari, K.6
  • 51
    • 84863739980 scopus 로고    scopus 로고
    • Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients
    • Fatima K, Paracha RZ, Qadri I. Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients. Mol Biol Rep 2012; 39: 5059-5067
    • (2012) Mol Biol Rep , vol.39 , pp. 5059-5067
    • Fatima, K.1    Paracha, R.Z.2    Qadri, I.3
  • 52
    • 66149108372 scopus 로고    scopus 로고
    • Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism
    • Secchiero P, Melloni E, di Iasio MG, Tiribelli M, Rimondi E, Corallini F, et al. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. Blood 2009; 113: 4300-4308
    • (2009) Blood , vol.113 , pp. 4300-4308
    • Secchiero, P.1    Melloni, E.2    di Iasio, M.G.3    Tiribelli, M.4    Rimondi, E.5    Corallini, F.6
  • 54
    • 77649207387 scopus 로고    scopus 로고
    • NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells
    • Hubmann R, Düchler M, Schnabl S, Hilgarth M, Demirtas D, Mitteregger D, et al. NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells. Br J Haematol 2010; 148: 868-878
    • (2010) Br J Haematol , vol.148 , pp. 868-878
    • Hubmann, R.1    Düchler, M.2    Schnabl, S.3    Hilgarth, M.4    Demirtas, D.5    Mitteregger, D.6
  • 55
    • 77956556489 scopus 로고    scopus 로고
    • Role of Wnt canonical pathway in hematological malignancies
    • Ge X, Wang X. Role of Wnt canonical pathway in hematological malignancies. J Hematol Oncol 2010; 3: 33
    • (2010) J Hematol Oncol , vol.3 , pp. 33
    • Ge, X.1    Wang, X.2
  • 56
    • 77958164865 scopus 로고    scopus 로고
    • LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
    • Gutierrez A, Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, Huddleston PM, et al. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood 2010; 116: 2975-2983
    • (2010) Blood , vol.116 , pp. 2975-2983
    • Gutierrez, A.1    Tschumper, R.C.2    Wu, X.3    Shanafelt, T.D.4    Eckel-Passow, J.5    Huddleston, P.M.6
  • 57
    • 77951675861 scopus 로고    scopus 로고
    • Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo
    • Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schlösser A, et al. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Neoplasia 2010; 12: 326-335
    • (2010) Neoplasia , vol.12 , pp. 326-335
    • Gandhirajan, R.K.1    Staib, P.A.2    Minke, K.3    Gehrke, I.4    Plickert, G.5    Schlösser, A.6
  • 59
    • 84861831963 scopus 로고    scopus 로고
    • Concurrent epigenetic silencing of Wnt/beta-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
    • Moskalev EA, Luckert K, Vorobjev IA, Mastitsky SE, Gladkikh AA, Stephan A, et al. Concurrent epigenetic silencing of Wnt/beta-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. BMC Cancer 2012; 12: 213
    • (2012) BMC Cancer , vol.12 , pp. 213
    • Moskalev, E.A.1    Luckert, K.2    Vorobjev, I.A.3    Mastitsky, S.E.4    Gladkikh, A.A.5    Stephan, A.6
  • 60
    • 64049104989 scopus 로고    scopus 로고
    • Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia
    • Wu QL, Zierold C, Ranheim EA. Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia. Blood 2009; 113: 3031-3039
    • (2009) Blood , vol.113 , pp. 3031-3039
    • Wu, Q.L.1    Zierold, C.2    Ranheim, E.A.3
  • 61
    • 33750017080 scopus 로고    scopus 로고
    • MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration
    • Redondo-Muñoz J, Escobar-Díaz E, Samaniego R, Terol MJ, García-Marco JA, García-Pardo A. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration. Blood 2006; 108: 3143-3151
    • (2006) Blood , vol.108 , pp. 3143-3151
    • Redondo-Muñoz, J.1    Escobar-Díaz, E.2    Samaniego, R.3    Terol, M.J.4    García-Marco, J.A.5    García-Pardo, A.6
  • 62
    • 78649302763 scopus 로고    scopus 로고
    • Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): A target for current and potential therapeutic options
    • Gandhirajan RK, Poll-Wolbeck SJ, Gehrke I, Kreuzer KA. Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options. Curr Cancer Drug Targets 2010; 10: 716-727
    • (2010) Curr Cancer Drug Targets , vol.10 , pp. 716-727
    • Gandhirajan, R.K.1    Poll-Wolbeck, S.J.2    Gehrke, I.3    Kreuzer, K.A.4
  • 63
    • 83455258135 scopus 로고    scopus 로고
    • Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms
    • Ok CY, Singh RR, Vega F. Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms. Am J Pathol 2012; 180: 2-11
    • (2012) Am J Pathol , vol.180 , pp. 2-11
    • Ok, C.Y.1    Singh, R.R.2    Vega, F.3
  • 64
    • 57749086958 scopus 로고    scopus 로고
    • Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: A potential new therapeutic target
    • Hegde GV, Peterson KJ, Emanuel K, Mittal AK, Joshi AD, Dickinson JD, et al. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Mol Cancer Res 2008; 6: 1928-1936
    • (2008) Mol Cancer Res , vol.6 , pp. 1928-1936
    • Hegde, G.V.1    Peterson, K.J.2    Emanuel, K.3    Mittal, A.K.4    Joshi, A.D.5    Dickinson, J.D.6
  • 65
    • 84856303562 scopus 로고    scopus 로고
    • Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL
    • Decker S, Zirlik K, Djebatchie L, Hartmann D, Ihorst G, Schmitt-Graeff A, et al. Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL. Blood 2012; 119: 997-1007
    • (2012) Blood , vol.119 , pp. 997-1007
    • Decker, S.1    Zirlik, K.2    Djebatchie, L.3    Hartmann, D.4    Ihorst, G.5    Schmitt-Graeff, A.6
  • 66
    • 84876112323 scopus 로고    scopus 로고
    • Dysregulation of janus kinases and signal transducers and activators of transcription in cancer
    • Costa-Pereira AP, Bonito NA, Seckl MJ. Dysregulation of janus kinases and signal transducers and activators of transcription in cancer. Am J Cancer Res 2011; 1: 806-816
    • (2011) Am J Cancer Res , vol.1 , pp. 806-816
    • Costa-Pereira, A.P.1    Bonito, N.A.2    Seckl, M.J.3
  • 67
    • 38349123079 scopus 로고    scopus 로고
    • The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways
    • de Totero D, Meazza R, Capaia M, Fabbi M, Azzarone B, Balleari E, et al. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood 2008; 111: 517-524
    • (2008) Blood , vol.111 , pp. 517-524
    • de Totero, D.1    Meazza, R.2    Capaia, M.3    Fabbi, M.4    Azzarone, B.5    Balleari, E.6
  • 68
    • 80053299704 scopus 로고    scopus 로고
    • The role of IL-21 in hematological malignancies
    • Ma J, Ma D, Ji C. The role of IL-21 in hematological malignancies. Cytokine 2011; 56: 133-139
    • (2011) Cytokine , vol.56 , pp. 133-139
    • Ma, J.1    Ma, D.2    Ji, C.3
  • 69
    • 84855987240 scopus 로고    scopus 로고
    • Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells
    • Dietrich S, Krämer OH, Hahn E, Schäfer C, Giese T, Hess M, et al. Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells. Clin Cancer Res 2012; 18: 417-431
    • (2012) Clin Cancer Res , vol.18 , pp. 417-431
    • Dietrich, S.1    Krämer, O.H.2    Hahn, E.3    Schäfer, C.4    Giese, T.5    Hess, M.6
  • 70
    • 39149134593 scopus 로고    scopus 로고
    • Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis
    • Marton S, Garcia MR, Robello C, Persson H, Trajtenberg F, Pritsch O, et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 2008; 22: 330-338
    • (2008) Leukemia , vol.22 , pp. 330-338
    • Marton, S.1    Garcia, M.R.2    Robello, C.3    Persson, H.4    Trajtenberg, F.5    Pritsch, O.6
  • 73
    • 67149147424 scopus 로고    scopus 로고
    • microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification
    • Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L, et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009; 113: 5237-5245
    • (2009) Blood , vol.113 , pp. 5237-5245
    • Stamatopoulos, B.1    Meuleman, N.2    Haibe-Kains, B.3    Saussoy, P.4    Van Den Neste, E.5    Michaux, L.6
  • 74
    • 67149099803 scopus 로고    scopus 로고
    • miRs: Fine-tuning prognosis in CLL
    • Sampath D, Calin GA. miRs: fine-tuning prognosis in CLL. Blood 2009; 113: 5035-5036
    • (2009) Blood , vol.113 , pp. 5035-5036
    • Sampath, D.1    Calin, G.A.2
  • 75
    • 78650861867 scopus 로고    scopus 로고
    • Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia
    • Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011; 305: 59-67
    • (2011) JAMA , vol.305 , pp. 59-67
    • Fabbri, M.1    Bottoni, A.2    Shimizu, M.3    Spizzo, R.4    Nicoloso, M.S.5    Rossi, S.6
  • 76
    • 79952392451 scopus 로고    scopus 로고
    • MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells
    • Li S, Moffett HF, Lu J, Werner L, Zhang H, Ritz J, et al. MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells. PLoS One 2011; 6: e16956
    • (2011) PLoS One , vol.6
    • Li, S.1    Moffett, H.F.2    Lu, J.3    Werner, L.4    Zhang, H.5    Ritz, J.6
  • 77
    • 5444276626 scopus 로고    scopus 로고
    • Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status
    • Haslinger C, Schweifer N, Stilgenbauer S, Döhner H, Lichter P, Kraut N, et al. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol 2004; 22: 3937-3949
    • (2004) J Clin Oncol , vol.22 , pp. 3937-3949
    • Haslinger, C.1    Schweifer, N.2    Stilgenbauer, S.3    Döhner, H.4    Lichter, P.5    Kraut, N.6
  • 79
    • 36148990723 scopus 로고    scopus 로고
    • Murine models of chronic lymphocytic leukaemia: Role of microRNA-16 in the New Zealand Black mouse model
    • Scaglione BJ, Salerno E, Balan M, Coffman F, Landgraf P, Abbasi F, et al. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br J Haematol 2007; 139: 645-657
    • (2007) Br J Haematol , vol.139 , pp. 645-657
    • Scaglione, B.J.1    Salerno, E.2    Balan, M.3    Coffman, F.4    Landgraf, P.5    Abbasi, F.6
  • 81
    • 34249661649 scopus 로고    scopus 로고
    • Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia
    • Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007; 109: 4944-4951
    • (2007) Blood , vol.109 , pp. 4944-4951
    • Fulci, V.1    Chiaretti, S.2    Goldoni, M.3    Azzalin, G.4    Carucci, N.5    Tavolaro, S.6
  • 82
    • 27244434788 scopus 로고    scopus 로고
    • A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
    • Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-1801
    • (2005) N Engl J Med , vol.353 , pp. 1793-1801
    • Calin, G.A.1    Ferracin, M.2    Cimmino, A.3    Di Leva, G.4    Shimizu, M.5    Wojcik, S.E.6
  • 83
    • 42949127525 scopus 로고    scopus 로고
    • miRNA analysis in B-cell chronic lymphocytic leukaemia: Proliferation centres characterized by low miR-150 and high BIC/miR-155 expression
    • Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 2008; 215: 13-20
    • (2008) J Pathol , vol.215 , pp. 13-20
    • Wang, M.1    Tan, L.P.2    Dijkstra, M.K.3    van Lom, K.4    Robertus, J.L.5    Harms, G.6
  • 84
    • 77952383254 scopus 로고    scopus 로고
    • Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia
    • Moussay E, Palissot V, Vallar L, Poirel HA, Wenner T, El Khoury V, et al. Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. Mol Cancer 2010; 9: 115
    • (2010) Mol Cancer , vol.9 , pp. 115
    • Moussay, E.1    Palissot, V.2    Vallar, L.3    Poirel, H.A.4    Wenner, T.5    El Khoury, V.6
  • 85
    • 84865164499 scopus 로고    scopus 로고
    • miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
    • Zhu DX, Zhu W, Fang C, Fan L, Zou ZJ, Wang YH, et al. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis 2012; 33: 1294-1301
    • (2012) Carcinogenesis , vol.33 , pp. 1294-1301
    • Zhu, D.X.1    Zhu, W.2    Fang, C.3    Fan, L.4    Zou, Z.J.5    Wang, Y.H.6
  • 86
    • 79953822796 scopus 로고    scopus 로고
    • MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
    • Vargova K, Curik N, Burda P, Basova P, Kulvait V, Pospisil V, et al. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood 2011; 117: 3816-3825
    • (2011) Blood , vol.117 , pp. 3816-3825
    • Vargova, K.1    Curik, N.2    Burda, P.3    Basova, P.4    Kulvait, V.5    Pospisil, V.6
  • 87
    • 77953004738 scopus 로고    scopus 로고
    • MicroRNA and proliferation control in chronic lymphocytic leukemia: Functional relationship between miR-221/222 cluster and p27
    • Frenquelli M, Muzio M, Scielzo C, Fazi C, Scarfò L, Rossi C, et al. MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27. Blood 2010; 115: 3949-3959
    • (2010) Blood , vol.115 , pp. 3949-3959
    • Frenquelli, M.1    Muzio, M.2    Scielzo, C.3    Fazi, C.4    Scarfò, L.5    Rossi, C.6
  • 88
    • 18744396337 scopus 로고    scopus 로고
    • Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
    • Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99: 15524-15529
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 15524-15529
    • Calin, G.A.1    Dumitru, C.D.2    Shimizu, M.3    Bichi, R.4    Zupo, S.5    Noch, E.6
  • 89
    • 73649116987 scopus 로고    scopus 로고
    • The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia
    • Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17: 28-40
    • (2010) Cancer Cell , vol.17 , pp. 28-40
    • Klein, U.1    Lia, M.2    Crespo, M.3    Siegel, R.4    Shen, Q.5    Mo, T.6
  • 90
    • 65549110908 scopus 로고    scopus 로고
    • miR-34a as part of the resistance network in chronic lymphocytic leukemia
    • Zenz T, Mohr J, Eldering E, Kater AP, Bühler A, Kienle D, et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2009; 113: 3801-3808
    • (2009) Blood , vol.113 , pp. 3801-3808
    • Zenz, T.1    Mohr, J.2    Eldering, E.3    Kater, A.P.4    Bühler, A.5    Kienle, D.6
  • 91
    • 79955506666 scopus 로고    scopus 로고
    • miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells
    • Zauli G, Voltan R, di Iasio MG, Bosco R, Melloni E, Sana ME, et al. miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin Cancer Res 2011; 17: 2712-2724
    • (2011) Clin Cancer Res , vol.17 , pp. 2712-2724
    • Zauli, G.1    Voltan, R.2    di Iasio, M.G.3    Bosco, R.4    Melloni, E.5    Sana, M.E.6
  • 92
    • 33846190181 scopus 로고    scopus 로고
    • Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181
    • Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006; 66: 11590-11593
    • (2006) Cancer Res , vol.66 , pp. 11590-11593
    • Pekarsky, Y.1    Santanam, U.2    Cimmino, A.3    Palamarchuk, A.4    Efanov, A.5    Maximov, V.6
  • 93
    • 67650632619 scopus 로고    scopus 로고
    • p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia
    • author reply 6499-6500
    • Rivetti di Val Cervo P, Tucci P, Majid A, Lena AM, Agostini M, Bernardini S, et al. p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia. Blood 2009; 113: 6498-6499; author reply 6499-6500
    • (2009) Blood , vol.113 , pp. 6498-6499
    • Rivetti di Val Cervo, P.1    Tucci, P.2    Majid, A.3    Lena, A.M.4    Agostini, M.5    Bernardini, S.6
  • 94
    • 65549088117 scopus 로고    scopus 로고
    • Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation
    • Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, et al. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood 2009; 113: 3744-3753
    • (2009) Blood , vol.113 , pp. 3744-3753
    • Sampath, D.1    Calin, G.A.2    Puduvalli, V.K.3    Gopisetty, G.4    Taccioli, C.5    Liu, C.G.6
  • 95
    • 84867813282 scopus 로고    scopus 로고
    • The Akt-associated microRNAs
    • Xu M, Mo YY. The Akt-associated microRNAs. Cell Mol Life Sci 2012; 69: 3601-3612
    • (2012) Cell Mol Life Sci , vol.69 , pp. 3601-3612
    • Xu, M.1    Mo, Y.Y.2
  • 97
    • 80052939685 scopus 로고    scopus 로고
    • miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia
    • Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M, et al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood 2011; 118: 3072-3079
    • (2011) Blood , vol.118 , pp. 3072-3079
    • Visone, R.1    Veronese, A.2    Rassenti, L.Z.3    Balatti, V.4    Pearl, D.K.5    Acunzo, M.6
  • 99
    • 36149000639 scopus 로고    scopus 로고
    • MicroRNAs in the pathogeny of chronic lymphocytic leukaemia
    • Nicoloso MS, Kipps TJ, Croce CM, Calin GA. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Br J Haematol 2007; 139: 709-716
    • (2007) Br J Haematol , vol.139 , pp. 709-716
    • Nicoloso, M.S.1    Kipps, T.J.2    Croce, C.M.3    Calin, G.A.4
  • 100
    • 84875531373 scopus 로고    scopus 로고
    • SOCS1 is significantly up-regulated in Nutlin-3-treated p53(wild-type) B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155
    • di Iasio MG, Norcio A, Melloni E, Zauli G. SOCS1 is significantly up-regulated in Nutlin-3-treated p53(wild-type) B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155. Invest New Drugs 2012; 30: 2403-2406
    • (2012) Invest New Drugs , vol.30 , pp. 2403-2406
    • di Iasio, M.G.1    Norcio, A.2    Melloni, E.3    Zauli, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.